Alpha-Ethyltryptamine

Jump to: navigation, search
Alpha-Ethyltryptamine
AET.png
150px
Identifiers
CAS Number
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H16N2
Molar mass188.27 g/mol
3D model (JSmol)
Melting point222 to 223 °C (Expression error: Unrecognized word "to". °F)

alpha-Ethyltryptamine (Etryptamine, α-ethyltryptamine, α-ET, or AET), is a psychoactive drug belonging to the tryptamine family. It was explored as an anti-depressant by Upjohn Chemical Company under the name Monase, but was withdrawn from commercial use after a year due to the unacceptable occurrence of agranulocytosis. It was moved into US Schedule I list of illegal substances in 1993. It is structurally related to α-methyltryptamine but its pharmacological effects are very different. α-ET is not a hallucinogenic drug, its effects resemble more that of the empathogen-entactogens like MDMA (Ecstasy). Alexander Shulgin, in TiHKAL, mentions that this compound has been used to alleviate unpleasant symptoms of opiate withdrawal.

Dosage

75-150 mg is commonly consumed orally for entactogenic effects. α-ET has a stereocenter and S-(+)-α-ET is the more active stereoisomer.

See also

External links

fi:Alfaetyylitryptamiini


Linked-in.jpg